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Coronary Flow Reserve Improves After Aortic
Valve Replacement for Aortic Stenosis: An
Adenosine Transthoracic Echocardiography Study
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OBJECTIVES The goal of this study was to assess coronary flow reserve (CFR) before and after aortic valve
replacement (AVR).
BACKGROUND Coronary flow reserve is impaired under conditions of left ventricular (LV) hypertrophy. It is
not known whether CFR improves with regression of LV hypertrophy in humans.
METHODS We investigated 35 patients with pure aortic stenosis, LV hypertrophy and normal coronary
arteriograms. Patients underwent adenosine transthoracic echocardiography on two occa-
sions—immediately before AVR and six months postoperatively. Left ventricular mass, distal
left anterior descending coronary artery (LAD) diameter, flow and CFR were assessed on
each occasion.
RESULTS Distal LAD diameter was successfully imaged in 30 patients (86%), and blood flow was
successfully imaged in 27 (77%). Paired data were subsequently available in 24 patients, of
whom 14 were men, mean age 68.1 6 12.5 years, body mass index 24.5 6 2.0 kg/m2, aortic
valve gradient 93 6 32 mm Hg. Pre- to post-AVR a significant decrease was seen in LV mass
(271 6 38 vs. 236 6 32g, p , 0.01) and LV mass index (154 6 21 vs. 134 6 21g/m2, p ,
0.01). Distal LAD diameter fell from 2.27 6 0.37 to 2.23 6 0.35 mm, p 5 0.08). Pre- to
post-AVR there was no significant change in resting parameters of peak diastolic velocity
(0.43 6 0.16 vs. 0.41 6 0.11 m/s), distal LAD flow 23.3 6 10.1 vs. 20.9 6 5.2 ml/min or
distal LAD flow scaled for LV mass (8.7 6 3.8 vs. 9.0 6 2.5 ml/min/100 g LV mass), but
there was significant increase in hyperemic peak diastolic velocity (0.71 6 0.26 vs. 1.08 6
0.24 m/s; p , 0.01), distal LAD flow (37.8 6 11.3 vs. 53.5 6 16.1 ml/min; p , 0.01) and
distal LAD flow scaled for LV mass (14.3 6 5.0 vs. 23.3 6 8.5 ml/min/100 g LV mass; p ,
0.01). Coronary flow reserve, therefore, increased from 1.76 6 0.5 to 2.61 6 0.7.
CONCLUSIONS Coronary flow reserve increases after AVR for aortic stenosis. This increase occurs in tandem
with regression of LV hypertrophy. (J Am Coll Cardiol 2000;36:1889–96) © 2000 by the
American College of Cardiology
Coronary flow reserve (CFR) is impaired in the presence of
left ventricular (LV) hypertrophy (1–3). Regression of LV
hypertrophy may, therefore, be accompanied by improve-
ment in CFR, and, indeed, there are animal studies that
suggest that this is the case (4–6). However, in humans, the
invasive nature of the assessment of CFR (usually under-
taken with intracoronary Doppler guidewires) has hitherto
prevented investigation of this hypothesis.
Transthoracic echocardiography has recently been shown
to be capable of measuring CFR (7–10), and we, therefore,
sought to utilize this simple noninvasive technique to assess
whether CFR improves after aortic valve replacement
(AVR).
METHODS
Study population. From October 1997 to June 1998,
patients awaiting AVR at this specialist cardiothoracic
center were identified from the surgical waiting list. On
admission patients were assessed for study eligibility.
Inclusion criteria were aortic stenosis with an aortic valve
gradient (on echocardiography or at catheterization)
$50 mm Hg; echocardiographic evidence of LV hypertro-
phy (11) and angiographically-normal coronary arteries.
Exclusion criteria were: a history of systemic hypertension
(systolic blood pressure .160 mm Hg or diastolic
.100 mm Hg on two or more occasions) and aortic
regurgitation .grade 1. Patients whose preoperative assess-
ments met these entry criteria were approached with a view
to recruitment. The study was approved by the local ethics
committee, and those participants who agreed to participate
gave written informed consent.
Study design in brief. Patients were recruited to undergo
adenosine transthoracic echocardiography on two occa-
sions—the day before AVR and six months postoperatively.
Left ventricular mass, distal left anterior descending coro-
nary artery (LAD) diameter, flow and CFR were to be
calculated on each occasion.
Echocardiographic equipment. Echocardiographic stud-
ies were performed by a single operator using a Vingmed
CFM 750 ultrasound unit. This utilizes annular phased
array technology and incorporates a 512-line scan converter.
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M-mode analysis of ventricular wall and cavity dimensions
was undertaken with a 3.5 MHz transducer. Two-
dimensional visualization of the LAD was undertaken with
a broad bandwidth 5 MHz transducer (focal length 40 mm,
lateral resolution 0.6 mm, axial resolution 0.3 mm). This
was operated at 6.3 MHz for maximum near-field resolu-
tion. Doppler analysis of blood flow was at 4 MHz.
Echocardiographic technique. Patients were asked to re-
frain from caffeine intake on the preoperative day and
similarly at the six-month review (12). In the echocardiog-
raphy laboratory a venous cannula was sited. Sublingual
glyceryl trinitrate (GTN) 400 mg was given to dilate and fix
epicardial coronary diameter in order to prevent further
flow-induced vasodilatation (13,14). Patients were placed in
the left lateral decubitus position. Simultaneous M-mode
analysis of interventricular septal thickness (IVST), LV
internal diameter (LVID) and posterior ventricular wall
thickness (PWT) was made at or just below the tips of the
mitral valve leaflets. A measurement of wall thickness was
made in diastole at the peak of the R wave according to the
Penn convention. Left ventricular mass was calculated using
the formula of Devereux et al. (15).
A low left parasternal window was employed to image the
LAD in cross-section as previously described (16–18). The
LV was imaged in short axis, and the distal LAD was
identified as a circular radiolucency lying in epicardial fat in
the anterior interventricular sulcus (Fig. 1). The ultrasound
probe was rotated counterclockwise 90° and was angled
laterally to allow Doppler analysis of the anterior interven-
tricular sulcus at the smallest possible incident angle. Simul-
taneous magnified color flow mapping identified the LAD
as a thin red diastolic jet (Fig. 2). Frame rate and low
velocity cut-off were minimized to optimize color-flow
imaging of resting coronary flow. The Doppler sampler was
adjusted to incorporate LAD data alone; wall motion signals
were rejected, and flow was analyzed (Fig. 3A). Through-
out, images were recorded on videotape for off-line analysis.
Once adequate images of resting LAD diameter and flow
had been obtained, a 6-min intravenous infusion of adeno-
sine was initiated (140 mg/kg/min) during which time
hyperemic LAD flow was recorded as above (Fig. 3B).
During the final minute of infusion, LAD diameter was
again recorded in short axis to exclude further flow-induced
vasodilatation (19).
Data collection. The Vingmed CFM 750 incorporates an
internal analysis package for use with the video playback
facility. Distal LAD diameter was measured at end-diastole
with internal calipers applied to endothelial borders; there-
fore, intraluminal diameter was gauged as previously vali-
dated (18). Peak velocities were read with spectrum calipers.
Velocity-time integral was computed from envelope tracings
of the Doppler signal over complete cardiac cycles, incor-
porating both systolic and diastolic envelopes. A mean of 3
measures was calculated for LAD diameter, flow velocity
Abbreviations and Acronyms
AVR 5 aortic valve replacement
BMI 5 body mass index
BSA 5 body surface area
CFR 5 coronary flow reserve
cosu 5 cosine incident angle of Doppler beam
GTN 5 glyceryl trinitrate
IVST 5 interventricular septal thickness
LAD 5 left anterior descending coronary artery
LV 5 left ventricle or ventricular
LVID 5 left ventricular internal diameter
LVMI5 left ventricular mass index
PWT 5 posterior wall thickness
VTI 5 velocity-time integral
Figure 1. A low left parasternal short axis section through the left ventricle.
The distal LAD is identified as a circular radiolucency with increased
circumferential opacification lying in the anterior interventricular sulcus.
IVS 5 interventricular septum; LAD 5 left anterior descending coronary
artery; LV 5 left ventricle; RV 5 right ventricle.
Figure 2. Low left parasternal long axis view of the anterior interventricular
sulcus. Distal LAD flow is visualized as a thin red diastolic flame. LAD 5
left anterior descending coronary artery; LV 5 left ventricle.
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and velocity-time integral (VTI). Heart rate was calculated
from R-R intervals of simultaneously recorded electrocar-
diograms.
Definitions, measurements and calculations
c Body surface area (BSA) was calculated from height and
body mass measurements according to the formula of
Du Bois and Du Bois (20): height (cm)0.725 3 mass
(kg)0.425 3 0.007184.
c Body mass index (BMI) was calculated as mass (kg)/
height (m)2.
c Left ventricular mass (LVM) was calculated according to
the Penn convention (15): LV mass 5 1.04 [(LVID 1
PWT 1 IVST)3 2 LVID3] 2 13.6 g.
c Left ventricular mass index (LVMI) was calculated as
LVM/BSA.
c Left ventricular hypertrophy was defined according to
Devereux’s criteria (11): LVMI . 134 g/m2 (men);
. 110 g/m2 (women).
c Coronary flow calculations were made according to the
method of Doucette et al. (21) (F 5 p(d/2)2 3 heart
rate 3 VTI (cm) 3 1/cosu 3 0.5. (F 5 flow [ml/min];
d 5 distal LAD; diameter [cm]; HR 5 heart rate
[beat/min]; VTI 5 velocity-time integral [cm]; cosu 5
cosine incident angle of Doppler beam.)
c Coronary flow reserve was calculated as: CFR 5 Fh/Fb
where Fh is hyperemic coronary flow; Fb is baseline
coronary flow.
Variability and validation. Reproducibility of echocardio-
graphic assessment of CFR, interobserver and intraobserver
variability, have been previously assessed at this institution
Figure 3. Doppler analysis of flow in the distal left anterior descending coronary artery before aortic valve replacement: (A) at rest and (B) during hyperemia.
Note reverse systolic flow.
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and have been found to be well within the limits of clinical
acceptability (22). For LAD diameter, interobserver vari-
ability was 3.7%; intraobserver variability was 3.2%, and
reproducibility was 4.1%. For CFR, interobserver variability
was 5.8%; intraobserver variability was 3.8%, and reproduc-
ibility was 9.1%. The technique has also been validated in
comparison with intracoronary Doppler guidewires, with
good correlation (7,23).
Statistics. Normality of data was assessed using P-P plots
and the one-sample Kolmogorov-Smirnov test. Paired data
were assessed with the Student t test or the Wilcoxon signed
ranks test, as appropriate. Data relating to LAD diameter
before and after AVR, with and without GTN, was ana-
lyzed using a two-way repeated measures analysis of vari-
ance test, incorporating the interaction term. Measurements
are given as mean (standard deviation) unless otherwise
indicated. Significance was accepted at the level p , 0.05.
RESULTS
Thirty-five patients were recruited to the study. Distal LAD
diameter was successfully imaged in 30 (86%), and blood
flow was imaged in 27 (77%). Patient characteristics are
shown in Table 1. All patients had LV hypertrophy by
echocardiographic criteria. Patients in whom LAD diame-
ter or flow were not imaged (n 5 8) tended to be older, with
greater BMI.
Of the 27 patients who, therefore, formed the study
group, one tolerated the adenosine infusion poorly and was
not asked to return; one moved out of the region and was
unable to return, and one patient died of multiorgan failure
postoperatively. Paired data were, therefore, available for 24
patients.
Mean time to follow-up echocardiogram was 171 (33)
days. Analysis of LV wall thickness, LV mass and distal
LAD diameter before and after AVR is shown in Table 2
and demonstrates reduction in LV indexes after AVR.
There was no statistically-significant reduction in distal
LAD diameter after AVR. Endothelium-independent
vasodilatation (after sublingual GTN) tended to be greater
after AVR, but, again, this did not reach statistical signifi-
cance.
Distal LAD flow velocities, flow volumes and flow
reserve are shown in Table 3. Reverse systolic flow was
observed in 15 patients before AVR (Fig. 3). Systolic flow
was often observed to be biphasic, with both retrograde and
antegrade components. Net systolic contribution to coro-
nary flow was, therefore, minimal. Resting and hyperemic
peak systolic velocities were both significantly greater after
AVR, as flow became antegrade. Resting peak diastolic
velocity decreased after AVR, while hyperemic peak dia-
stolic velocity increased (Fig. 4). Resting LAD flow was,
therefore, similar before and after AVR, but hyperemic flow
was significantly greater after AVR, particularly once cor-
rected for LV mass. Coronary flow reserve was, therefore,
significantly greater after AVR.
DISCUSSION
We have demonstrated that CFR in aortic stenosis improves
after AVR. This improvement occurs in tandem with
regression of LV hypertrophy following relief of outflow
tract obstruction. We suggest that regression of LV hyper-
trophy is likely to be the main mechanism whereby CFR
improves after AVR.
The effect of LV pressure overload on CFR has been
widely studied both in animals (1,2,4–6,24–30) and hu-
Table 2. Ventricular Parameters and Distal LAD Diameter Before and After AVR
Parameter Pre-AVR Post-AVR p Value
IVST (mm) 13.9 (1.2) 12.6 (1.1) , 0.01
LVID (mm) 45.4 (4.0) 44.1 (3.1) NS
PWT (mm) 13.5 (1.3) 12.3 (1.1) , 0.01
LVM (g) 271 (38) 226 (32) , 0.01
LVMI (g/m2) 156 (21) 129 (21) , 0.01
Angle correction 37 (9) 36 (8) NS
Distal LAD diameter (mm) 2.27 (0.37) 2.23 (0.35) 0.07
Distal LAD diameter post-GTN (mm) 2.37 (0.38) 2.35 (0.35) NS
% diameter increase post-GTN 4.4 (3.3) 5.6 (4.6) NS
Figures in parentheses represent standard deviations.
AVR 5 aortic valve replacement; GTN 5 glyceryl trinitrate; IVST 5 interventricular septal thickness; LAD 5 left anterior
descending coronary artery; LVID 5 left ventricular internal diameter; LVM 5 left ventricular mass; LVMI 5 left ventricular
mass index; PWT 5 posterior wall thickness.
Table 1. Patient Characteristics (n 5 27)
Variable
Age (yrs) 68.1 (12.5)
BSA (m2) 1.77 (0.17)
BMI (kg/m2) 24.5 (2.0)
Gender (M:F ratio) 14:10
NYHA class 1,2,3,4 2,16,6,0
CCS angina scale 0,1,2,3,4 5,12,6,1,0
Mean blood pressure (mm Hg) 134 (20)/89 (10)
Cardiac rhythm (SR:AF) 21:3
Aortic valve gradient (mm Hg) 93 (32)
Aortic regurgitation grade
0 11
1 13
Figures in parentheses represent standard deviations.
AF 5 atrial fibrillation; BMI 5 body mass index; BSA 5 body surface area; CCS
5 Canadian Cardiovascular Society; NYHA 5 New York Heart Association; SR 5
sinus rhythm.
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mans (3,31–37). Without exception, these studies have
revealed impairment of CFR in the presence of LV hyper-
trophy. The effect on CFR of changes in ventricular
hypertrophy, however, have been less extensively studied.
CFR and regression of LV hypertrophy. Five animal
studies have been undertaken examining the effect of re-
gression of LV hypertrophy on CFR (4–6,30,38). In all of
these studies CFR improved after regression of experimen-
tal LV hypertrophy, although Ito et al. (30) found improve-
ment only after short-term, as opposed to long-term,
hypertrophy.
There are two human studies concerning the effect of
relief of pressure overload on CFR. Doty et al. (39)
examined CFR intraoperatively during surgery for supraval-
vular aortic stenosis and found that CFR did not immedi-
ately improve despite reduction of the outflow gradient.
They concluded that regression of LV hypertrophy was
required for improvement in CFR. Eberli et al. (35)
investigated patients with aortic valve disease. This study
was, however, compromised by the fact that study groups
before and after AVR consisted of entirely different patients.
Coronary flow reserve was found to be greater among
postoperative patients. In our study we have compared the
same patients pre- and postoperatively and have considered
a homogeneous group with aortic stenosis alone. Paired data
are therefore available, providing statistically-robust evi-
dence that CFR improves after AVR for aortic stenosis.
Transthoracic imaging of the distal LAD. Transthoracic
echocardiographic imaging of distal LAD diameter and
flow has a reported success rate of 30% to 90%, depending
on patient selection (8,17,18,23,40–42). Success rates are
higher for patients with LV hypertrophy, who have greater
coronary diameter (41,42) and in younger, leaner subjects
(22). They are lower for patients who are older, of greater
BMI or who have coronary artery disease (40). Our success
rate of 77% in this study is in keeping with previous results.
Recent work using intravenous contrast agents, however,
suggests that improved success rates might be achieved with
this technique in the future (10,23).
LV wall thickness and mass. Patients with aortic stenosis
have increased IVST, PWT and LV mass (37,43–45).
Mean measurements in this study of IVST (13.9 mm) LV
mass (271 g) and LVMI (154 g) are representative (37,45).
The effect of AVR on ventricular parameters has been
widely studied (46–51). Most authors have reported an
approximately 10% reduction in wall thickness and an
approximately 25% reduction in LVMI in the first year after
AVR. Over the long term, LV hypertrophy continues to
regress (48,50). We demonstrated a 9% reduction in IVST
and a 17% reduction in LVMI six months after AVR.
LAD diameter. Coronary artery diameter increases in the
presence of LV hypertrophy (45,52–56). However, the
increase is not proportional to the increase in muscle mass
(45,56), and this results in relative “inadequacy” of the
coronary circulation, rendering the myocardium susceptible
to ischemia in the absence of coronary stenoses (3,31).
Distal LAD diameter in normal individuals is 1.9 6
0.4 mm, increasing to 2.1 6 0.5 mm in men with LV
hypertrophy (55). Our measurements of 2.3 6 0.4 mm for
patients with marked LV hypertrophy are in keeping with
these.
The effect of regression of LV hypertrophy on coronary
diameter has also been studied (57,58). Under these circum-
stances, coronary cross-section decreases proportionately
less than does ventricular hypertrophy, with the result that
the ratio of coronary cross-section to LV mass normalizes.
We demonstrated a decrease in distal LAD diameter after
AVR, though this did not reach statistical significance.
The effect of nitrocompounds on coronary diameter has
been widely studied (13,42,56,59–61). In individuals with-
out coronary artery disease, distal LAD diameter may be
expected to increase by approximately 20% with 400 mg
sublingual GTN (42,59). For patients with LV hypertro-
phy, however, the degree of vasodilatation is significantly
reduced as a result of structural remodeling of the vascular
wall (42,56,60). We noted an increase of 4.4% in distal
LAD diameter in response to 400 mg sublingual GTN,
consistent with previous data, and a nonsignificant trend
towards greater coronary vasodilatation in response to sub-
lingual GTN after partial regression of LV hypertrophy.
LAD flow. Distal LAD flow comprises a small systolic and
a larger diastolic component. Under conditions of LV
hypertrophy, the characteristic pattern of coronary flow is
altered, with decreased diastolic deceleration (62). Interpre-
tation of flow volumes depends on how data are presented.
Baseline coronary flow is augmented, but baseline coronary
Table 3. Distal Left Anterior Descending Coronary Artery Flow Velocities and Flow Reserve Before and After AVR
Variable
Resting Hyperemia
Pre-AVR Post-AVR p Value Pre-AVR Post-AVR p Value
PSV (m/s) 0.05 (0.11) 0.16 (0.08) , 0.01 0.02 (0.26) 0.25 (0.21) , 0.01
PDV (m/s) 0.43 (0.16) 0.41 (0.11) NS 0.71 (0.26) 1.08 (0.24) , 0.01
VTI (mm) 15.4 (6.7) 13.4 (3.4) NS 22.5 (5.2) 30.2 (5.2) , 0.01
Heart rate (beats/min) 70 (11) 73 (9) NS 78 (11) 81 (7) NS
Flow (ml/min) 23.3 (10.1) 20.9 (5.2) NS 37.8 (11.3) 53.5 (16.1) , 0.01
Flow (ml/min/100 g LV mass) 8.7 (3.8) 9.0 (2.5) NS 14.3 (5.0) 23.3 (8.5) , 0.01
Coronary Flow Reserve 1.76 (0.5) 2.61 (0.7) < 0.01
Figures in parentheses represent standard deviations.
AVR 5 aortic valve replacement; PDV 5 peak diastolic velocity; PSV 5 peak systolic velocity; VTI 5 velocity time integral.
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flow per 100 g LV mass is normal. Hyperemic blood flow is
normal, but hyperemic blood flow per 100 g LV mass is
impaired (1,2,28,31,63,64).
In aortic stenosis interpretation of coronary flow is further
complicated by reverse systolic flow. Intramyocardial pres-
sure, myocardial bulk and the Bernouilli effect created by the
jet of high-velocity supraaortic flow combine to generate
reverse systolic flow in a significant proportion of patients
(41,65,66). After surgical correction of outflow obstruction,
systolic flow normalizes in the majority of patients (41). We
found reverse systolic flow in 15 patients before AVR (Fig.
3) and in two after AVR. Mean systolic contribution to
forward flow was, therefore, minimal both at rest and during
hyperemia before AVR.
Resting peak diastolic velocity and flow were both greater
than comparative values assessed by the same technique in
normal controls (22). Post-AVR hyperemic coronary flow
scaled for ventricular mass was also similar to that recorded
in normal individuals as predicted by Nitenberg and Antony
(64).
Study limitations. The main limitation of adenosine trans-
thoracic echocardiography is that imaging is not possible in
all subjects. This factor has limited widespread application
of the technique. Additionally, only the distal LAD can be
adequately visualized. Nonetheless, as a truly noninvasive
means of assessing CFR, adenosine transthoracic echocar-
diography shows promise, and imaging success may be
optimized by the use of intravenous contrast agents (10,23).
Continuous monitoring of blood pressure was not under-
taken. However, for a given coronary perfusion pressure
Figure 4. Doppler analysis of flow in the distal left anterior descending coronary artery after aortic valve replacement: (A) at rest and (B) during hyperemia.
Note the forward systolic flow, the reduced resting peak diastolic velocity and the increased hyperemic peak diastolic velocity.
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(within limits of autoregulation) alterations in aortic pres-
sure produce parallel increases in basal and maximal coro-
nary flow, such that CFR remains the same (67,68).
In recording blood flow, angles of incidence above 30° are
undesirable as cosu begins to assume greater overall impor-
tance (cos 30 5 0.87). However, the prime purpose of the
study was comparison of CFR, which, as a ratio, was
unaffected by the angle of incidence in a given study.
Accurate measurement of CFR depends on obtaining
true resting coronary flow. Echocardiography is relatively
unstressful and certainly less so than coronary angiography,
but, even in this study, true resting flow may not have been
achieved in all participants, thus artificially reducing CFR.
Conclusions. Coronary flow reserve improves after AVR
for aortic stenosis. This improvement occurs in association
with regression of LV hypertrophy. Transthoracic adeno-
sine echocardiography continues to be a promising tech-
nique for the evaluation of CFR.
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